Patient P-02181
Synthetic patientMETA-24 · Day 168 · 55–64 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
30%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
- Day 16 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 16.
Primary contributors, last 14 days
- Treatment adherence+11
- Nutritional resilience+7
- Inflammatory activity+4
- GI instability+2
- Toxicity+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable19 min
stable · +0.4 vs previous 14 d
Sleep duration
Wearable6.8 h
stable · +0.2 vs previous 14 d
Energy level
Daily log5.6/10
stable · +0.2 vs previous 14 d
Steps
Wearable2,455
stable · +74 vs previous 14 d
GI burden
Companion28/100
stable · -0.2 vs previous 14 d
Adherence
Companion97.3 %
stable · -3.1 vs previous 14 d
Sleep quality
Wearable42.8/100
improving · +2.9 vs previous 14 d
Glucose, CGM daily mean
CGM125 mg/dL
stable · -5.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 63 from the failing basin, 24 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -4.5 next day on high-intake days · n 21
Would not help
- Keep ultra-processed lowGI +4 next day on high-intake days · n 18
- Keep simple carbs lowGI +2.7 next day on high-intake days · n 20
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-4.5supporter · 95%
- Ultra-processed food+4detractor · 95%
- Simple carbohydrates+2.7detractor · 75%
- Alcohol-1.5no signal · 33%
- Insoluble fibre-1.4no signal · 25%
- Dietary fat load-0.6no signal · 15%
- Histamine load+0.5no signal · 15%
- Caffeine+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↓20
- Wearable2,455 steps/day
- Inflammatory signalling ↑15
- WearableHRV 29 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 2.8 · butyrate capacity 71/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 32 ms
- Sleep
- 6.8 h
- Steps
- 3,726
- Resting HR
- 58 bpm
Daily log: GI score 28, nutritional resilience 62, adherence 97.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.